SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity. SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity

Name: SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity. SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity
Published: 2022-07-31T00:00:00+08:00

NIAID Data Ecosystem2026-03-13 收录

抗肿瘤机制

树突状细胞信号

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA864050 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

创建时间：

2022-07-31

SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity. SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity

资源简介：

相关数据集